SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Cheryl Galt who wrote (23963)8/5/1998 7:59:00 AM
From: Henry Niman  Respond to of 32384
 
Cheryl, Actually, the Biotech downtrend seems to have affected the hit frequency on Links to Ligand at home.att.net
Last week there were over 1000 hits to that page alone, and a high percentage were from Biotechs (and the diversity was the biggest that I've seen over a one week time frame).



To: Cheryl Galt who wrote (23963)8/5/1998 8:04:00 AM
From: Mudcat  Read Replies (2) | Respond to of 32384
 
Thanks for the informative posts Cheryl. I've been trying to get your same points across for over a year now but the yea-sayers just don't listen.



To: Cheryl Galt who wrote (23963)8/5/1998 10:23:00 AM
From: bob smith  Respond to of 32384
 
>>The wishful thinking and rosy speculation on this thread probably cheer some of you
during this downturn. Just be aware that it might also color your expectations and
decision making. That cheer might lead to deep disappointment --- and, for some
retirees, financial ruin. Due diligence involves a lot more than listening to Henry and
"studying" Links-to-Ligand and the Breakout thread.<<

I couldn't agree more!

Great posts and it's good to have you back.

Bob



To: Cheryl Galt who wrote (23963)8/5/1998 12:28:00 PM
From: aknahow  Read Replies (1) | Respond to of 32384
 
Cheryl, thanks for the thoughtful post. I agree with your concept that the impact of the market can be more important than what is happening at an individual company. I also agree that the Asian crisis effects have a wider range or impact than some like myself may have assumed. I do not know that the information you have on Asians having been big buyers of biotech stocks is correct. I would be interested in the source. Even so, I think it is difficult to ignore the fact that money is fungible. So even if their investments were in Treasuries a repatriation of these funds would impact the stock market, including biotechs. But, the repatriation theory has yet to be proven. The weaker ones home economy gets the more it seems, in practice, those that are able to, get their money out. Yes, the flow out probably slows down as they earn less, but fear goes up, so even this is not clear cut. I guess any crisis impacts most sectors and only after it's over can one look back to find those that were not hurt and understand why they weren't.

BTW TSC mentions what some "experts" are looking at as potential buys. Biotecs were mentioned by two of those quoted. BTW James Cramer, of TSC, does not like biotechs. LGND was not mentioned nor any of the stocks I have followed.

thestreet.com